Harrison Conrad J, Geoghegan Luke, Sidey-Gibbons Chris J, Stirling Paul H C, McEachan Jane E, Rodrigues Jeremy N
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Headington, Oxford, UK.
Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK.
Plast Reconstr Surg Glob Open. 2022 Apr 18;10(4):e4279. doi: 10.1097/GOX.0000000000004279. eCollection 2022 Apr.
Carpal tunnel syndrome (CTS) is extremely common and typically treated with carpal tunnel decompression (CTD). Although generally an effective treatment, up to 25% of patients do not experience meaningful benefit. Given the prevalence, this amounts to considerable morbidity and cost without return. Being able to reliably predict which patients would benefit from CTD preoperatively would support more patient-centered and value-based care.
We used registry data from 1916 consecutive patients undergoing CTD for CTS at a regional hand center between 2010 and 2019. Improvement was defined as change exceeding the respective QuickDASH subscale's minimal important change estimate. Predictors included a range of clinical, demographic and patient-reported variables. Data were split into training (75%) and test (25%) sets. A range of machine learning algorithms was developed using the training data and evaluated with the test data. We also used a machine learning technique called chi-squared automatic interaction detection to develop flowcharts that could help clinicians and patients to understand the chances of a patient improving with surgery.
The top performing models predicted functional and symptomatic improvement with accuracies of 0.718 (95% confidence interval 0.660, 0.771) and 0.759 (95% confidence interval 0.708, 0.810), respectively. The chi-squared automatic interaction detection flowcharts could provide valuable clinical insights from as little as two preoperative questions.
Patient-reported outcome measures and machine learning can support patient-centered and value-based healthcare. Our algorithms can be used for expectation management and to rationalize treatment risks and costs associated with CTD.
腕管综合征(CTS)极为常见,通常采用腕管减压术(CTD)进行治疗。尽管该治疗一般有效,但仍有高达25%的患者未获得显著益处。鉴于其患病率,这意味着大量的发病率和成本却没有相应回报。能够在术前可靠地预测哪些患者将从CTD中获益,将有助于提供更以患者为中心和基于价值的医疗服务。
我们使用了2010年至2019年间在一个地区手部中心连续接受CTD治疗CTS的1916例患者的登记数据。改善被定义为变化超过各自QuickDASH子量表的最小重要变化估计值。预测因素包括一系列临床、人口统计学和患者报告的变量。数据被分为训练集(75%)和测试集(25%)。使用训练数据开发了一系列机器学习算法,并使用测试数据进行评估。我们还使用了一种名为卡方自动交互检测的机器学习技术来开发流程图,以帮助临床医生和患者了解患者手术改善的可能性。
表现最佳的模型预测功能和症状改善的准确率分别为0.718(95%置信区间0.660,0.771)和0.759(95%置信区间0.708,0.810)。卡方自动交互检测流程图从仅两个术前问题就能提供有价值的临床见解。
患者报告的结局指标和机器学习可以支持以患者为中心和基于价值的医疗保健。我们的算法可用于期望管理,并使与CTD相关的治疗风险和成本合理化。